Doctors’ prescribing habits are influenced by drug reps and other industry marketing.
Monkey Business Images/Shutterstock
Too often, pharmaceutical companies and device manufacturers exert influence in how their products are tested in the research phase and recommended in the clinic.
When drug companies and drug regulators, such as Health Canada, sit down together at “pre-submission meetings” this may have a negative impact on public health.
Drug companies have a job to do and so does Health Canada. When the relationship becomes murky, the public are at risk.
Nearly all medical product recalls are voluntarily issued by firms, instead of mandated by the FDA.
Every year, thousands of medical devices and drugs are recalled in the US. But the decision to recall a flawed product is often left up to the manufacturer.
Purdue faces about 2,000 lawsuits related to the opioid crisis.
AP Photo/Toby Talbot
OxyContin maker Purdue has reportedly been mulling a bankruptcy filling, just as the first of around 2,000 lawsuits against it prepares to go to trial.
Classified advertisement for Leslie Keeley’s Gold Cure.
ProQuest Historical Newspapers: Chicago Tribune, July 21, 1884
Considered in historical context, Purdue's plan to peddle opioid addiction medicines to vulnerable people is not so surprising. Gilded-Age pharmaceutical companies used similar strategies.
How will each drug interact with the proteins in your body?
Artificially intelligent drug design programs could discover new therapies for conditions that are difficult or prohibitively expensive to cure.
A new review of 372 patient group submissions to the Canadian Agency for Drugs or Technology in Health – about whether new medicines should be covered by public plans – reveals a total of 1896 conflicts of interest.
A new study reveals how many patient groups lobby for new drugs to be funded by public plans in Canada -- all while receiving funding from the companies manufacturing the drugs in question.
The lack of transparency seems to be worse in certain disease areas, including diabetes and heart disease.
Clinical guidelines have a big impact on the care you receive and the drugs you're prescribed. But one in five doctors who write these guidelines have undisclosed ties to drug companies.
The Chronic Pain Association of Canada has received money from Eli Lilly Canada Inc., Purdue Canada Inc. and Merck Frosst Canada. A blog post on the association’s website contains messages favourable to increased opioid use.
Evidence shows that opioid manufacturers fund patient advocacy groups in Canada, distorting policies to protect public health.
Pharmaceutical companies have traditionally been the ones to develop drugs. But for rare diseases university researchers may play a role.
Developing drugs is typically the domain of large pharmaceutical companies. But here is an example of drug development for a rare pediatric brain cancer that was done in a university setting.
The Family Medicine Forum, Nov. 9, 2017, the Palais des congrès de Montréal.
This week's annual Family Medicine Forum is an opportunity for your family doctor -- to cave or resist in the face of Big Pharma sponsorship and marketing.
Biohacking for cures: what you need to know.
Research shows that money and meals from the pharmaceutical industry do increase the amount doctors prescribe the drugs being marketed.
Big Pharma in Canada is far behind the curve when it comes to disclosing what payments to health-care professionals are for.
Warren Buffett of Berkshire Hathaway, Jeff Bezos of Amazon and Jamie Dimon of JPMorgan Chase created a health venture in January.
AP File Photos.
Noted physician and author Atul Gawande was named CEO of a new health care venture aimed at cutting costs and improving care. But the most important man to keep an eye on in this effort isn't Gawande. It's the middleman.
As of June 2018, the U.S. is short on 182 drugs and medical supplies, including IV bags.
Sherry Yates Young/shutterstock.com
The US is currently short on 182 drugs and medical supplies. The problem isn't new, but it's frustrating health care workers.
President Donald Trump releases a ‘blueprint’ to reduce prescription drug prices, with Health and Human Services Secretary Alex Azar, in the Rose Garden of the White House in Washington, May 11, 2018.
(AP Photo/Carolyn Kaster)
The logic behind U.S. president Donald Trump's proposal that Canada and other countries have been “free-riding” off high prices in the United States is bizarre at best.
How a technology born from finance – the blockchain – can help the pharmaceutical industry to carry out clinical trials that protect patients.
The Saint Regis Mohawk tribe has struck a multimillion-dollar deal with Allergan. But the deal may do more harm than good.
Michelle Holley holds a photograph of her daughter Jaime Holley, 19, who died of a heroin overdose in November 2016.
Lynne Sladky/AP Photo
Your guide to a public health crisis that's likely to get worse.
Schedule 2 narcotics: Morphine Sulfate, OxyContin and Opana.
Rich Pedroncelli/AP Photo
How can we fight the opioid epidemic? Redesign the drugs, rethink how we assess patients and mandate prescription monitoring.